TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950
Angela Lackner, Sofia I. Picucci, Wenjin Jiang, Janset Onyuru, Melissa Campos, Julia Elise Cabral, Lemuel Leonidas, Alijah Macapagal, Hannah J. Lee, Valerie Henriquez, Karen Wang, Huilin Xu, Yanfei Qiu, Lauren Veronica Albrecht, Hal M. Hoffman, Reginald McNulty
This paper shows that TH5487 and SU0268 inhibit NLRP3 activation in FCAS patient PBMCs, overcoming resistance to MCC950 by blocking inflammasome assembly and reducing IL-1β secretion.
Communications Biology · Apr 16, 2026Peer-reviewedImmunology